Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Cyclacel Pharmaceuticals (CYCC) Q2 2024 Earnings
CYCC
14
May
Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-6.23
-4.27
-2.32
-0.36
Details
Expected EPS
-4.745
Actual EPS
-2.27
Surprise EPS
2.48
Surprise Percent
+52.16%
Description
Cyclacel Pharmaceuticals (CYCC) has reported earnings of -2.27 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login